Molecular genetics of ADHD: Prospects for novel therapies

Florence Levy*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Attention deficit hyperactivity disorder has been shown to be a highly heritable disorder, leading to an increasing interest In genetic studies. While multiple genes may be involved, the candidate gene approach is based on postulated neurotransmitter mechanisms. Molecular genetic advances in relation to dopaminergic (dopamine transporter, dopamine D4 receptor and dopamine D5 receptor) genes, adrenergic, serotonergic and nicotinic receptor genes are reviewed. Comorbidity of attention deficit hyperactivity disorder with learning disability is discussed and possible genetic Influences briefly reviewed. Recent pharmacogenomic studies of ADHD are reviewed and promising pathways suggested. Treatments 5 years from now may be more individually tailored in terms of gene/phenotype relationships.

Original languageEnglish
Pages (from-to)491-497
Number of pages7
JournalExpert Review of Neurotherapeutics
Issue number4
Publication statusPublished - 2002
Externally publishedYes


  • Dopamine receptor genes
  • Dopamine transporter
  • Dyslexia
  • Guanfacine
  • Methylphenidate
  • Nicotinic receptor
  • Norepinephrine
  • Serotonin


Dive into the research topics of 'Molecular genetics of ADHD: Prospects for novel therapies'. Together they form a unique fingerprint.

Cite this